HUTCHMED (China) (HCM) Assets Average (2016 - 2026)
HUTCHMED (China) (HCM) posted quarterly Assets Average of $980.9 million for Q2 2026, down 100.0% year-over-year from $81951.4 billion in Q2 2025, and down 1.97% quarter-over-quarter from $1.0 billion in Q4 2025.
HUTCHMED (China) (HCM) Assets Average (2016 - 2026) Analysis & Trends
HUTCHMED (China) (HCM) has reported Assets Average for 10 consecutive years, with $980.9 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Assets Average fell 100.0% year-over-year to $980.9 million; the TTM figure through Jun 2026 stood at $980.9 million (down 100.0% YoY), while the FY2025 annual figure was $81651.1 billion, changed 0.0% from the prior year.
- Assets Average eased to $980.9 million in Q2 2026 per HCM's latest filing, from $1.0 billion in the prior quarter.
- Across five years, Assets Average topped out at $81951.4 billion in Q2 2025 and bottomed at $630.5 million in Q2 2024.
- Historically, Assets Average has averaged $18212.0 billion across 5 years, with a median of $714.5 million in 2023.
- Annual changes were most pronounced in 2025 — Assets Average soared 12997415.61% — and 2026, when it slumped 100.0%.
- HUTCHMED (China)'s Assets Average stood at $663.0 million in 2022, then declined by 2.13% to $648.8 million in 2023, then soared by 12630495.76% to $81951.1 billion in 2024, then slumped by 100.0% to $1.0 billion in 2025, then slipped by 1.97% to $980.9 million in 2026.
- Business Quant data shows HCM's Assets Average at $980.9 million in Q2 2026, $1.0 billion in Q4 2025, and $81951.4 billion in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 5.97 Bn |
| 10 | HUTCHMED (China) | 2.17 Bn | 2.17 Bn | - | 980.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 980.92 Mn |
| Dec 31, 2025 | 1.00 Bn |
| Jun 30, 2025 | 81,951.40 Bn |
| Dec 31, 2024 | 81,951.14 Bn |
| Jun 30, 2024 | 630.52 Mn |
| Dec 31, 2023 | 648.83 Mn |
| Jun 30, 2023 | 714.55 Mn |
| Dec 31, 2022 | 662.97 Mn |
| Jun 30, 2022 | 685.28 Mn |
| Dec 31, 2021 | 724.55 Mn |
| Jun 30, 2021 | 983.00 Mn |
| Mar 31, 2021 | 865.85 Mn |
| Dec 31, 2020 | 782.08 Mn |
| Jun 30, 2020 | 468.84 Mn |
| Mar 31, 2020 | 412.12 Mn |
| Dec 31, 2019 | 433.11 Mn |
| Sep 30, 2019 | 474.65 Mn |
| Jun 30, 2019 | 517.26 Mn |
| Mar 31, 2019 | 535.71 Mn |
| Dec 31, 2017 | 471.32 Mn |